483
Recipharm MontsRecipharm Monts – FDA 483, Nov 12, 2019
Record Details
Recipharm Monts, a sterile drug manufacturer in Monts, France, was cited for deficiencies related to equipment qualification and record keeping during an FDA inspection. The firm failed to maintain records of equipment inspections and did not adequately perform installation qualifications for its labeling, packaging, and filling lines. These issues indicate a lack of proper control over critical manufacturing equipment.
View Company Profile
ID · 8da3ebc9-c75d-42d0-9fd6-150cb677753c
Other documents for Recipharm Monts
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.